Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 211835

Expand all

APREPITANT (APREPITANT)
40MG
Marketing Status: Prescription

Active Ingredient: APREPITANT
Proprietary Name: APREPITANT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211835
Product Number: 001
Approval Date: Oct 21, 2020
Applicant Holder Full Name: TORRENT PHARMA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

APREPITANT (APREPITANT)
80MG
Marketing Status: Prescription

Active Ingredient: APREPITANT
Proprietary Name: APREPITANT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211835
Product Number: 002
Approval Date: Oct 21, 2020
Applicant Holder Full Name: TORRENT PHARMA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

APREPITANT (APREPITANT)
125MG
Marketing Status: Prescription

Active Ingredient: APREPITANT
Proprietary Name: APREPITANT
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 125MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211835
Product Number: 003
Approval Date: Oct 21, 2020
Applicant Holder Full Name: TORRENT PHARMA INC
Marketing Status:  Prescription
Patent and Exclusivity Information